Jul 30, 2020
The COVID-19 pandemic has brought the Life Sciences Industry to an inflection point. It has exposed the limitations of traditional linear supply chain models, highlighted the need for sustainability and accelerated the move towards digital transformation.
Will the COVID-19 pandemic act as a catalyst for biopharma companies to recognise their vulnerabilities and accelerate the digital transformation of their global supply chain models?
In the third episode of Life Sciences Connect, we explore the digital transformation of the biopharma supply chain and adoption of AI powered technology.